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Introduction
Susceptibility-Weighted Magnetic Resonance Imag-
ing in the Evaluation of Dementia 
James P. Larsen, M.D., William Britt, III, Ph.D., Daniel Kido, M.D., Brenda L. Bartnik Olson, 
Ph.D., Barbara A. Holshouser, Ph.D., and Wolff M. Kirsch, M.D.
An 88-year-old woman with a clinical diagnosis of Alzheimer’s disease and advanced dementia, was 
evaluated with standard MRI of the brain as well as Susceptibility Weighted Imaging (SWI) with the 
MRI. SWI revealed more extensive brain microhemorrhages than standard MRI techniques, allowing 
the radiologic diagnosis of cerebral amyloid angiopathy. SWI shows promise as a more sensitive diag-
nostic tool than standard brain MRI for the evaluation of patients with dementia.
Neuroimaging techniques currently used for demen-
tia evaluations are in a state of evolution with continued 
reassessments and reports of enhanced diagnostic accuracy 
[1-2]. Conventional CT and MRI brain imaging detects 
potentially treatable causes of dementia such as “normal 
pressure hydrocephalus,” chronic subdural hematoma, 
strokes, and mass lesions [3]. PET scanning and MRI evi-
dence of medial temporal lobe atrophy have been shown 
to be both sensitive and specific for diagnosing Alzheimer’s 
disease [4-5]. Gradient-echo T2* (GE-T2*) weighted 
MR imaging detects cerebral microhemorrhages in lobar 
and subcortical patterns, findings that are considered 
highly suggestive for late-onset sporadic cerebral amyloid 
angiopathy [6-8].
Microhemorrhages associated with Alzheimer’s disease 
may be an underestimated cause of progressive cogni-
tive impairment in the elderly [9]. SWI is significantly 
more sensitive than GE-T2* MRI technique for detecting 
iron-dependent blood products [11]. SWI has been used 
in the evaluation of trauma, tumors, vascular malforma-
tions and neurodegenerative diseases [12]. We report a case 
of dementia with a clinical diagnosis of AD and compare 
conventional GE-T2* MRI with SWI MRI. In this case, 
the SWI demonstrated more extensive microhemorrhage 
involvement of the brain than GE-T2* imaging. 
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Case Report on her daughter and granddaughter to answer questions. 
The neurological examination included normal fundu-
scopic and cranial nerve function, motor, sensory, cer-
ebellar function as well as deep tendon reflex and plantar 
responses. A detailed neuropsychological evaluation and 
Clinical Dementia Rating (CDR) was attempted. The Sum 
of Boxes score on the CDR was 16.0 with a global CDR of 
3.0, consistent with severe dementia.
Laboratory tests to include serum electrolytes, renal, 
thyroid liver function, and serum B12 level were within 
normal limits.
The patient did not have prior brain imaging. Conven-
tional T1, T2, and FLAIR MRI at 1.5T revealed two to 
three microhemorrhages in the cerebellum. Conventional 
GE-T2* images also showed several superficial areas of 
hypointensity (Fig. 1a). SWI images revealed significantly 
more numerous microhemorrhages involving both cerebral 
hemispheres, notably in the occipital lobes, as well as 
cerebellum (Fig. 1b).
This patient is still alive so there is no brain specimen 
available for pathological correlation. 
Figure 1. 88-year-old woman with severe dementia. Axial GE-T2* MRI and corresponding SWI MRI through the centrum semio-
vale. A, The GE-T2* image shows two small foci of hemorrhage in the right parietal lobe. B, The corresponding SWI image shows 
numerous hemorrhages in the frontal and parietal lobes.
An 88-year-old woman with a history of diabetes 
mellitus type II, medically controlled mild hypertension, 
asthma/chronic obstructive pulmonary disease, interstitial 
lung disease, and osteopenia presented to our gerontology 
service with a two-year history of slow but progressive cog-
nitive impairment. Available history was obtained from the 
patient’s daughter and granddaughter. The patient was liv-
ing with her daughter and interacting on a daily basis with 
her family. Nothing in the neurological history suggested 
a neurovascular disorder - but rather a slow but progres-
sive dementing process. There was no history of sudden or 
progressive motor or sensory defects, seizure disorders or 
headaches. Specifically, there was no history of unilateral 
extremity or facial weakness, diplopia, dysarthria, aphasia 
or sudden stepwise deterioration in cognitive function. 
There was no family history of dementia in her parents 
or siblings despite long life spans. There was no history of 
concussion or head trauma.
On physical examination, the patient was alert and con-
versant but with obvious signs of cognitive loss. She relied 
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Discussion
Figure 2. Increase in mean transit time (MTT), cerebral blood 
flow (CBF), and blood volume (CBV) within the periphery of 
the cerebellum. The absence of abnormal signal change in 
CMRO2 image suggests normal brain oxygen metabolism.
GE-T2* MR brain imaging is currently the “standard” 
for identifying microhemorrhages and diagnosing “pos-
sible” or “probable” cerebral amyloid angiopathy in life, 
based on number and distribution of microhemorrhages 
[6, 8]. SWI MR brain imaging may be superior to GE-T2* 
for the detection of brain microhemorrhages. We report 
the first use of SWI to evaluate a patient with a clinical 
diagnosis of Alzheimer’s disease.
SWI MR brain imaging may have significant clinical ap-
plication. The differential diagnosis of microhemorrhages 
would include hypertension, trauma and cavernomas. 
Although there is no pathologic specimen for correlation, 
the appearance and distribution of the microhemorrhages 
are most consistent with cerebral amyloid angiopathy. 
Cerebral amyloid angiopathy with microhemorrhages 
is known to be prevalent in patients with Alzheimer’s 
disease [10], but may be unrecognized on clinical evalu-
ation and standard brain imaging. The demonstration of 
more numerous microhemorrhages on SWI, as compared 
to GE-T2*, may represent a more sensitive method for 
detecting cerebral amyloid angiopathy as a contributing 
factor to the patient’s dementia. The early detection of 
cerebral amyloid angiopathy associated microhemorrhages 
in patients with Alzheimer’s type dementia has significant 
clinical utility in that the presence of brain microhemor-
rhages are a risk factor for further significant intracranial 
hemorrhages. Identification of microhemorrhages may 
result in clinical recommendations to avoid anticoagulants 
and anti-platelet therapies in addition to substances with 
anticoagulant potential [14-15].
Systematic and sequential studies using SWI to evaluate 
mild cognitive impairment and dementia may help eluci-
date the apparent relationship of cerebral amyloid angiopa-
thy and microhemorrhages to Alzheimer’s disease.
In conclusion, SWI brain MRI is a new, sensitive 
technology for the detection of cerebral microhemor-
rhages. This case report illustrates the potential of SWI 
for increased sensitivity in diagnosing microhemorrhages 
than previously available. SWI may have significant utility 
in the clinical management of patients with dementia and 
Alzheimer’s disease as well as significant research applica-
tions to define the role of cerebral amyloid angiopathy and 
microhemorrhages in the pathophysiology of dementia. 
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